白质超强度和血管痴呆风险:系统性审查和元分析
Wei Luo1,2, Zhiqiang Dai3, Wenjing Wu1,2
1Department of Radiology, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
PeerJ
|June 20, 2025
概括
与其他认知障碍组相比,血管痴呆症 (VaD) 患者在MRI上显示出明显更高的白质超强度 (WMH) 量. 这突显了脑血管病理在VaD发展和诊断中的作用.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 老年学是一门学科.
背景情况:
- 在MRI上白质过强度 (WMH) 表明大脑小血管疾病.
- WMH与认知障碍和脑血管病理有关,可能导致血管痴呆症 (VaD).
- 需要进一步澄清的是,WMH负担与VaD严重程度之间的准确关联.
研究的目的:
- 量化白质超强度体积和血管痴呆症严重程度之间的关系.
- 阐明白质高强度在血管痴呆症的发病过程中的作用.
主要方法:
- 一项系统的文献搜索确定了15项涉及4061名患者的研究.
- 分析比较了血管痴呆症 (VaD) 患者的WMH体积与非认知障碍 (NCI),认知障碍没有痴呆症 (CIND) 和阿尔茨海默病 (AD) 组.
- 大脑MRI被用来评估WMH体积和水平.
主要成果:
- 与NCI,CIND和AD组相比,患有VaD的患者表现出明显更高的白质超强度体积.
- WMH与大脑血管病理相关;不规则和周周血管WMH对VaD更具特异性.
- 敏感性分析和统计测试表明了潜在的出版偏差.
结论:
- 在VaD患者中,WMH负担更大,加强了脑血管病理学的重要性.
- 标准化成像,多模式生物标志物和预测模型对于早期的VaD诊断和治疗至关重要.
- 这些发现支持针对血管痴呆症的向治疗策略.
更多相关视频
05:12A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
Published on: November 22, 2024
727
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
40.4K
相关概念视频
01:30Dementia
182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
182
01:26Alzheimer's Disease: Overview
684
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
684